Cowboy Ventures Backs Basata $21M Series A for Healthcare Ops
Cowboy Ventures joined Basata’s $21M Series A to automate healthcare operations, part of a busy 2026 that also included leading Petual’s seed round.
series-a — Venture Capital Articles & Research
Explore our latest articles on series-a — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Why This Topic Matters in VC
- Deal flow signal: Funding activity and investor conviction in series-a
- Fundraising context: Which investors are active and what traction they expect
- Market timing: Sector momentum, valuation benchmarks, and competitive dynamics
Browse all series-a articles below, or use our investor list to research active investors by stage and sector.
Related Articles (33 articles)
-
-
Cantos Backs Heaviside Industries $28M Series A in Defense Tech
Cantos backed Heaviside Industries’ $28M Series A (May 2026). That round is historical: the live mark is $600M after a $60M Series B on August 12, 2026.
-
Greycroft Leads Jesse & Ben’s $10M and Recursive Series A Rounds
Greycroft led Jesse & Ben’s $10M Series A clean-label food round and Recursive Superintelligence’s Series A, spanning consumer brands and AI.
-
Notation Capital Backs Photon Health $16M Series A
Notation Capital backed Photon Health’s $16M Series A, a follow-on to its earlier lead, staying true to its NYC pre-seed roots.
-
Forerunner Ventures Leads Casa Series A for Homeownership OS
Forerunner Ventures led the Series A for Casa, a homeownership operating system, continuing to deploy its $500M Fund VII into consumer-facing software.
-
AlleyCorp Leads Clarasight $11.5M Series A for Enterprise T&E AI
AlleyCorp led Clarasight’s $11.5M Series A to modernize enterprise travel and expense management with AI, part of a fast start to 2026 for the NYC firm.